4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-098488
Chief Operating Officer sold 2,014 shares at $28.93 ($58,265)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gault Cheryl Chief Operating Officer | 2026-03-05 | Sale | −2,014 | $28.93 | $58,265 | 169,914 | D: show line 1 in the form |
| Open-market sales · 2,014 sh · avg $28.93 · $58,265 | |||||||
Loading xslF345X05/ownership.xml…